Furthermore, the significant association of CKS2, TOP2A, and PARP1 identified through PPI analysis highlights the potential importance of these genes in developing BC treatment strategies targeting the hsa_circ_0001946/miR-7-5p axis. This evidence concerns the gene PARP1 and breast cancer.